摘要
目的研究分析急性脑梗死患者的血液黏度在接受中药活血化瘀联合治疗后和单用中药后的临床改善情况。方法根据2013年10月～2014年6月我院的326例非溶栓急性脑梗死患者进行研究分析,将患者分组为A和B组,A组使用单药治疗,B组使用联合治疗,对两组患者的临床治疗情况进行分析,收集患者治疗10～14 d后的血液黏度情况对比分析。结果 B组患者的临床各项指标改善情况比A组略优,但是两组结果差异不具有统计学意义（P〉0.05）。两组的意外事件发生几率相近,差异无统计学意义（P〉0.05）。结论活血化瘀中药联合用药和单药治疗对患者血液黏度改善情况没有显著差异性,因此临床中尽量避免联合用药,减少患者的经济支出,防止不良反应产生。
Objective To study the clinical improvement of blood viscosity in patients with acute cerebral infarction and the clinical improvement after receiving the treatment of combined chinese medicine for blood stasis and removing blood stasis. Methods 326 patients with acute cerebral infarction were divided into A group and B group from October 2013 to June 2014. A group was treated with single drug, B group was treated by combined therapy. The clinical treatment of two groups were analyzed. Results The clinical indexes of patients in B group were better than those in A group, but the results of the two groups were not statistically significant（P〉0.05）. The probability of accidental events in the two groups was similar, no significant difference（P〉0.05）. Conclusion The combined use of activating blood and removing blood stasis and the use of blood viscosity of patients are not significantly different from that of patients. Therefore, it is possible to avoid combined use, reduce the patient＇s economic expenses and prevent adverse reactions.
出处
《中国继续医学教育》
2015年第32期181-182,共2页
China Continuing Medical Education
关键词
脑梗死
血液黏度
活血化瘀
Cerebral infarction
Blood viscosity
Promoting blood circulation and removing blood stasis
